<DOC>
	<DOCNO>NCT01151319</DOCNO>
	<brief_summary>This randomise , placebo-controlled , single-blind study design evaluate safety immunogenicity three novel HIV vaccine .</brief_summary>
	<brief_title>Safety Immunogenicity Study Three Candidate HIV-1 Vaccines , Administered Combination Healthy HIV-1 Uninfected Adults</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male female , assess medical history , physical examination laboratory test . 2 . Aged least 18 year day screen great 50 year day first vaccination . 3 . Willing comply requirement protocol available followup plan duration study . 4 . In opinion principal investigator designee , volunteer understood information provide . Written informed consent must give studyrelated procedure perform . 5 . Willing undergo HIV1 testing , HIV1 counsel receive HIV1 test result . 6 . If heterosexually active female ; use effective method contraception ( e.g . hormonal contraception , diaphragm , intrauterine device ( IUD ) , condom , anatomical sterility self partner ) 14 day prior first vaccination least 6 week last vaccination ; female volunteer must willing undergo urine pregnancy test time point specify protocol . 7 . If heterosexually active male ; willing use effective method contraception ( condom ; anatomical sterility self partner ) day first vaccination 6 week last vaccination . 8 . Willing forgo donation blood study . 1 . Any clinically significant acute chronic medical condition consider progressive , opinion principal investigator designee , would make volunteer unsuitable study . 2 . Any following abnormal laboratory parameter list : Haematology Haemoglobin &lt; 10.0 g/dl Absolute Neutrophil Count ( ANC ) ≤ 1000 /mm3 ( ≤ 1 x 109 /l ) Absolute Lymphocyte Count ( ALC ) ≤ 600 /mm3 ( ≤ 1 x 109 /l ) Platelets ≤100,000 /mm3 , ≥ 550,000 /mm3 ( ≤ 90 /l , ≥ 550 /l ) Biochemistry Creatinine &gt; 1.3 x ULN Aspartate aminotransferase ( AST ) &gt; 2.5 x ULN Alanine aminotransferase ( ALT ) &gt; 2.5 x ULN Urinalysis Abnormal dipstick confirm microscopy 3 . Reported highrisk behaviour HIV infection . Highrisk behaviour HIV1 infection define follow . Within previous 6 month volunteer : Had unprotected vaginal anal sex know HIVinfected person casual partner ( i.e. , continue , establish relationship ) Engaged sex work money drug Used injection drug Acquired one follow sexually transmit disease ( STD ) ; Chlamydia , gonorrhoea syphilis . 4 . Confirmed HIV1 HIV2 infection . 5 . If female , pregnant planning pregnancy within 6 week last vaccination ; lactate . 6 . Receipt live attenuate vaccine within previous 60 day ( live attenuate flu vaccine within 14 day ) plan receipt within 60 day vaccination Investigational Product receipt vaccine within previous 14 day plan receipt within14 day vaccination Investigational Product . 7 . Receipt blood transfusion blood product within previous 6 month . 8 . Participation another clinical trial Investigational Product currently , within previous 3 month expect participation study . 9 . Receipt investigational HIV vaccine within last 6 year . 10 . History severe severe local systemic reactogenicity event , history severe severe allergic reaction . 11 . Confirmed diagnosis hepatitis B virus ( surface antigen , HBsAg ) , hepatitis C virus ( HCV antibody ) active syphilis . 12 . Smallpox vaccination within previous 3 year ( smallpox vaccination prior 3 year document exclusion criterion ) . 13 . Major psychiatric illness include history schizophrenia severe psychosis , bipolar disorder require therapy , suicidal attempt ideation previous 3 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>